High body-mass index and multiple myeloma risk: insights from the global burden of disease 2021 study and identification of core target genes

The above findings underscore the growing public health threat posed by high BMI-associated MM and highlight the need for targeted interventions. SLC25A13 and THOC2 may play an important role in high BMI-associated MM and could serve as potential treatment targets in the future.